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312a Monday, February 17, 2014of the C2A-C2B interaction and may provide insight into the membrane fusion
activity of this protein.
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Chronic manipulation of synaptic activity drives bidirectional alterations in
synaptic efficacy. Compensatory tuning of presynaptic neurotransmitter
release maintains levels of synaptic activity within an optimal range for effi-
cient information processing. This homeostatic form of plasticity is apparent
in cultured hippocampal neurons and appears to involve the ubiquitin-
proteasome system (UPS). Examination of presynaptic mechanisms underly-
ing homeostatic plasticity has identified multiple positive regulators of exocy-
tosis subject to proteasomal degradation. However, homeostatic compensation
can involve up- or down-regulation of exocytosis and substantially less is
known of the negative regulation of vesicle release. Tomosyn, a presynapti-
cally active SNARE protein, is unique in that it is cytosolic and serves to
potently inhibit vesicle release at central synapses. Proteomic analysis of to-
mosyn revealed an interaction with the E3 ubiquitin-ligase HRD1. Here we
aim to test the hypothesis that the UPS serves as an activity-dependent mech-
anism to precisely regulate tomosyn proteostasis, and in turn manipulates
exocytosis. Consistent with this hypothesis, endogenous tomosyn levels in
cultured rat hippocampal neurons (18-25 DIV) increase following application
of the proteasome inhibitors MG132 (50mM, 4h) and lactacystin (10mM, 4h).
Moreover, our data indicate that the tomosyn-HRD1 interaction is activity-
dependent, as chronic AMPAR blockade (CNQX, 24h) results in an increase
in HRD1 co-immunoprecipitation with tomosyn and consequentially a
decrease in overall tomosyn protein level. To assess tomosyn’s role homeostat-
ic plasticity we use an optical reporter of exocytosis, vGlut1-pHluorin. Results
show that chronic activity blockade via CNQX (40mM, 24h) enhances vesicle
release in response to a stimulus train (10Hz, 10s) as compared to non-
stimulated controls. This effect is dependent upon tomosyn, as shRNA-
mediated tomosyn knock-down mitigates the compensatory enhancement of
exocytosis. These data strongly implicate tomosyn as a key presynaptic molec-
ular target which is subject to regulation by the UPS and facilitates activity-
dependent homeostatic plasticity.
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Homeostatic synaptic plasticity (HSP) maintains circuits within a dynamic
range suitable for encoding information. HSP-induced changes in neurotrans-
mission result from chronic increases in activity and lead to compensatory de-
creases in vesicle release (and vice versa). One mechanism for modulating
release in response to a homeostatic challenge is to shift the fractional size
of resting vs. recycling vesicle pools. In addition, strong evidence indicates
that cyclin-dependent kinase 5 (CDK5) is critical for determining the fraction
of vesicles in the resting, non-releasable state. Although CDK5 activity
strongly affects synaptic release, the specific mechanism(s) exerting this func-
tion remains unknown. Current investigations aim to identify and characterize
the CDK5 effector pathway that is required for its maintenance of the resting
pool of vesicles. Here we test the hypothesis that tomosyn, a soluble R-SNARE
protein is this CDK5 effector. Indeed our data indicate that tomosyn can be
phosphorylated by CDK5 in vitro. We next determined the functional reliance
of CDK5 on the presence of tomosyn by knocking-down (KD) or overexpress-
ing (OE) tomosyn. These experiments utilized cultured rat hippocampal neu-
rons (15-21 DIV) expressing vGLUT1-pHluorin, an optical reporter of
vesicle release. Tomosyn KD increased mobilization of vesicles into recycling
(active) pools (68% vs. 51% of totally releasable pool (TRP) in control); and,
conversely, tomosyn OE resulted in a decrease in the recycling pool (36% of
TRP). Pharmacological inhibition of CDK5 via roscovitine (100mM, 30m)
mirrored the tomosyn KD results wherein a significantly greater fraction of ves-
icles appeared in a releasable state (70% of TRP). Importantly, combination of
the two perturbations (tomosyn KD þ roscovitine) did not result in an additive
increase in the releasable pool (72% of TRP) further demonstrating that CDK5
and tomosyn likely exert control over vesicle release through a common
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Previously we demonstrated that activation of Gq protein-coupled H1 hista-
mine receptors potentiates stimulus-coupled exocytosis in bovine chromaffin
cells, despite inhibiting Ca2þ influx through voltage-gated calcium channels
(VGCCs). This potentiation is restricted to the immediately releasable pool
(IRP) of vesicles coupled to VGCCs, and requires the priming protein
Munc13-1. Doc2B is a calcium-binding protein, known to interact with
Munc13 to promote exocytosis; whether it plays a role in agonist-
regulated exocytosis is unknown. To address this question, we isolated
chromaffin cells from Doc2B (þ/þ), (þ/-) and (-/-) mice and examined
the effects of PLC-coupled GPCR activation on depolarization-evoked
exocytosis.
We found that under control stimulus conditions, depolarization-evoked
exocytosis, measured as changes in membrane capacitance, was not signif-
icantly different between Doc2B (þ/þ), (þ/-) and (-/-) cells; similarly no
differences were found between the sizes of the releasable vesicle pools
(IRP, RRP, SRP). Equimolar replacement of extracellular Ca2þ by Ba2þ
also revealed no significant differences in the synchronous and asynchro-
nous phases of Ba2þ-evoked exocytosis in Doc2B (þ/þ), (þ/-) or (-/-)
cells. Finally, although more than 80% of cells, independent of their geno-
type, responded to histamine with a reduction of Ca2þ influx, potentiation
of exocytosis was surprisingly modest (2-fold) and, even in Doc2 (þ/þ)
cells rarely observed (5/17 cells, (þ/-): 5/24 cells, (-/-): 2/18). This is in
stark contrast to bovine cells, where 80% of the cells show a 5-fold poten-
tiation of exocytosis. Importantly, Doc2B (þ/þ), (þ/-) and (-/-) cells re-
sponded to the DAG analog PMA with potentiation. Taken together, the
results suggest that there are profound species differences in the coupling
between GqPCRs and the exocytotic machinery in chromaffin cells and
that Doc2B is not required for agonist-dependent potentiation of exocytosis
in mice.
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The nuclear pore complex (NPC) is a large multi-protein assembly that medi-
ates the selective transport of molecules between the cytoplasm and nucleus in
eukaryotic cells. While the factors involved in various transport pathways are
largely known, the physical mechanism by which the NPC supports both effi-
cient and selective molecular translocation remains unclear. We have identified
a component of the NPC selectivity barrier consisting of the transport receptor
importin-b and the nucleoporin Nup153 which can be modulated by the
GTPase Ran. We have investigated importin-b and Nup153’s effect on the ki-
netic rates of both passive and active nuclear import and its regulation by Ran.
Furthermore, using photobleach step counting and super-resolution imaging,
we have characterized the numbers and spatial distributions of importin-b
within the pore suggesting that this transport receptor is a functional and sur-
prisingly stable component of the NPC. Finally, we demonstrate in vitro with
fluorescence fluctuation spectroscopy that importin-b and Nup153 bind to
form large cross-linked complexes which can be dispersed by RanGTP. Our re-
sults suggest that importin-b in conjunction with Nup153 can constitute a selec-
tive ’gate’ in the NPC whose permeability towards both inert and transport-
competent cargos is sensitive to RanGTP.
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The nuclear pore complex, NPC, is responsible for selectively conducting
transport to/from the nucleus in eukaryotes. While we are entering the sixth
